Vyne Therapeutics (VYNE) Q4 2025 Earnings

Nov 6Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.3
-0.25
-0.19
-0.13

Details

Expected EPS
-0.173333
Actual EPS
-0.17
Surprise EPS
0
Surprise Percent
+1.92%

Description

⁨Vyne Therapeutics⁩ (⁦VYNE⁩) has reported earnings of ⁦-0.17⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts